Result: Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial

Title:

Involved:

Published:

Freiburg : Universität, 2021

Scope:

1 Online-Ressource

Format:

eBook

Language:

English

Notes:

Trials. - 22, 1 (2021) , 343, ISSN: 1745-6215

DOI:

10.1186/s13063-021-05181-0

Additional information